Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05852938
PHASE3

A Study of Zigakibart in Adults With IgA Nephropathy

Sponsor: Novartis Pharmaceuticals

View on ClinicalTrials.gov

Summary

Safety and Efficacy of BION-1301 in Adults with IgA Nephropathy

Official title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study of BION-1301 in Adults With IgA Nephropathy (The BEYOND Study)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

383

Start Date

2023-07-06

Completion Date

2028-01-25

Last Updated

2026-04-01

Healthy Volunteers

No

Interventions

DRUG

BION-1301

BION-1301 Pre-Filled Syringe (PFS) 600mg subcutaneous administration every 2 weeks for 104 weeks.

DRUG

Placebo

Placebo - PFS subcutaneous administration every 2 weeks for 104 weeks.

Locations (200)

University of Alabama at Birmingham: The Kirklin Clinic

Birmingham, Alabama, United States

Nephrology Consultants, LLC

Huntsville, Alabama, United States

University of California, San Francisco

San Francisco, California, United States

Valiance Clinical Research

South Gate, California, United States

University of Colorado Hospital

Aurora, Colorado, United States

Denver Nephrology Research Division

Denver, Colorado, United States

Vida Medical Centers - Pembroke Pines

Pembroke Pines, Florida, United States

NorthShore University HealthSystem

Evanston, Illinois, United States

Nephrology Associales of Northern Illinois and Indiana

Hinsdale, Illinois, United States

Nephrology Associates of Northern Illinois and Indiana - 7836 W Jefferson Blvd

Fort Wayne, Indiana, United States

University Of Iowa Hospitals And Clinics

Iowa City, Iowa, United States

Intermed Consultants

Edina, Minnesota, United States

Capital District Renal Physicians

Clifton Park, New York, United States

Nephrology Associates PC - Flushing

Flushing, New York, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

University of Cincinnati College of Medicine - 231 Albert Sabin Way

Cincinnati, Ohio, United States

Cleveland Clinic-9500 Euclid Ave

Cleveland, Ohio, United States

OHSU - Oregon Clinical and Translational Research Institute

Portland, Oregon, United States

Northeast Clinical Research Center, LLC

Bethlehem, Pennsylvania, United States

Columbia Nephrology Associates , P.A. - Columbia

Columbia, South Carolina, United States

Knoxville Kidney Center, PLLC - Frenova F1

Knoxville, Tennessee, United States

Dallas Renal Group - 1411 N Beckley Ave

Dallas, Texas, United States

Dallas Renal Group - Waxachie - 2460 N. I-35

Dallas, Texas, United States

DaVita Clinical Research

El Paso, Texas, United States

University of Texas MD Anderson Cancer Center-1155 Pressler

Houston, Texas, United States

East Texas Nephrology Associates

Lufkin, Texas, United States

Nephrology Associates of Northern Virginia-8501 Arlington Blvd

Fairfax, Virginia, United States

Swedish Center for Comprehensive Care

Seattle, Washington, United States

Novartis Investigative Site

La Plata, Buenos Aires, Argentina

Novartis Investigative Site

Catamarca, Catamarca Province, Argentina

Novartis Investigative Site

Barracas, Ciudad Autónoma de BuenosAires, Argentina

Novartis Investigative Site

Rosario, Santa Fe Province, Argentina

Novartis Investigative Site

Santa Fe, Santa Fe Province, Argentina

Novartis Investigative Site

Buenos Aires, Argentina

Novartis Investigative Site

Gosford, New South Wales, Australia

Novartis Investigative Site

Kogarah, New South Wales, Australia

Novartis Investigative Site

Liverpool, New South Wales, Australia

Novartis Investigative Site

Penrith, New South Wales, Australia

Novartis Investigative Site

St Leonards, New South Wales, Australia

Novartis Investigative Site

Cairns North, Queensland, Australia

Novartis Investigative Site

Box Hill, Victoria, Australia

Novartis Investigative Site

St Albans, Victoria, Australia

Novartis Investigative Site

Bonheiden, Antwerpen, Belgium

Novartis Investigative Site

Ghent, Oost-Vlaanderen, Belgium

Novartis Investigative Site

Roeselare, West-Vlaanderen, Belgium

Novartis Investigative Site

Liège, Belgium

Novartis Investigative Site

Lodelinsart, Belgium

Novartis Investigative Site

Woluwe-Saint-Lambert, Belgium

Novartis Investigative Site

Santana, Amapá, Brazil

Novartis Investigative Site

Belo Horizonte, Minas Gerais, Brazil

Novartis Investigative Site

Maringá, Paraná, Brazil

Novartis Investigative Site

Porto Alegre, Rio Grande do Sul, Brazil

Novartis Investigative Site

Joinville, Santa Catarina, Brazil

Novartis Investigative Site

São Bernardo do Campo, São Paulo, Brazil

Novartis Investigative Site

São Paulo, São Paulo, Brazil

Novartis Investigative Site

São Paulo, Brazil

Novartis Investigative Site

Vancouver, British Columbia, Canada

Novartis Investigative Site

Brampton, Ontario, Canada

Novartis Investigative Site

East York, Ontario, Canada

Novartis Investigative Site

London, Ontario, Canada

Novartis Investigative Site

Toronto, Ontario, Canada

Novartis Investigative Site

Greenfield Park, Quebec, Canada

Novartis Investigative Site

Montreal, Quebec, Canada

Novartis Investigative Site

Hefei, Anhui, China

Novartis Investigative Site

Beijing, Beijing Municipality, China

Novartis Investigative Site

Foshan, Guangdong, China

Novartis Investigative Site

Guangzhou, Guangdong, China

Novartis Investigative Site

Guangzhou, Guangdong, China

Novartis Investigative Site

Shenzhen, Guangdong, China

Novartis Investigative Site

Nanning, Guangxi, China

Novartis Investigative Site

Guiyang, Guizhou, China

Novartis Investigative Site

Wuhan, Hubei, China

Novartis Investigative Site

Nanjing, Jiangsu, China

Novartis Investigative Site

Nantong, Jiangsu, China

Novartis Investigative Site

Wuxi, Jiangsu, China

Novartis Investigative Site

Nanchang, Jiangxi, China

Novartis Investigative Site

Jinan, Shandong, China

Novartis Investigative Site

Qingdao, Shandong, China

Novartis Investigative Site

Shanghai, Shanghai Municipality, China

Novartis Investigative Site

Taiyuan, Shanxi, China

Novartis Investigative Site

Taiyuan, Shanxi, China

Novartis Investigative Site

Chengdu, Sichuan, China

Novartis Investigative Site

Ürümqi, Xinjiang, China

Novartis Investigative Site

Wulumuji, Xinjiang, China

Novartis Investigative Site

Hangzhou, Zhejiang, China

Novartis Investigative Site

Taizhou, Zhejiang, China

Novartis Investigative Site

Zagreb, City of Zagreb, Croatia

Novartis Investigative Site

Biškupec Zelinski, Croatia

Novartis Investigative Site

Rijeka, Croatia

Novartis Investigative Site

Vinkovci, Croatia

Novartis Investigative Site

Prague, Praha, Hlavní Mesto, Czechia

Novartis Investigative Site

Nîmes, Gard, France

Novartis Investigative Site

Lille, Nord, France

Novartis Investigative Site

Lyon, Rhône, France

Novartis Investigative Site

Grenoble, France

Novartis Investigative Site

Paris, France

Novartis Investigative Site

Paris, France

Novartis Investigative Site

Augsburg, Bavaria, Germany

Novartis Investigative Site

Hanover, Lower Saxony, Germany

Novartis Investigative Site

Hanover, Lower Saxony, Germany

And 100 more locations on ClinicalTrials.gov